CH624112A5 - - Google Patents
Download PDFInfo
- Publication number
- CH624112A5 CH624112A5 CH330477A CH330477A CH624112A5 CH 624112 A5 CH624112 A5 CH 624112A5 CH 330477 A CH330477 A CH 330477A CH 330477 A CH330477 A CH 330477A CH 624112 A5 CH624112 A5 CH 624112A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pyridine
- phenyl
- nicotinic acid
- hours
- nicotinoyl
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 13
- -1 amino, phenyl Chemical group 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 4
- 229920000877 Melamine resin Polymers 0.000 description 4
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- PMFYBARNDLWOAX-UHFFFAOYSA-N n-(4,6-diamino-1,3,5-triazin-2-yl)pyridine-3-carboxamide Chemical compound NC1=NC(N)=NC(NC(=O)C=2C=NC=CC=2)=N1 PMFYBARNDLWOAX-UHFFFAOYSA-N 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- GJPPFXYQKGBTSB-UHFFFAOYSA-N n-(triazin-4-yl)pyridine-3-carboxamide Chemical class C=1C=CN=CC=1C(=O)NC1=CC=NN=N1 GJPPFXYQKGBTSB-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- VPODXHOUBDCEHN-UHFFFAOYSA-N pyridine-3-carbonyl pyridine-3-carboxylate Chemical compound C=1C=CN=CC=1C(=O)OC(=O)C1=CC=CN=C1 VPODXHOUBDCEHN-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- DXTVYXOAQBXYAU-UHFFFAOYSA-N chloro ethyl carbonate Chemical compound CCOC(=O)OCl DXTVYXOAQBXYAU-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- CNTIXUGILVWVHR-UHFFFAOYSA-N diphosphoryl chloride Chemical compound ClP(Cl)(=O)OP(Cl)(Cl)=O CNTIXUGILVWVHR-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3494976A JPS52118483A (en) | 1976-03-29 | 1976-03-29 | Nicotinylaminotriazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH624112A5 true CH624112A5 (xx) | 1981-07-15 |
Family
ID=12428406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH330477A CH624112A5 (xx) | 1976-03-29 | 1977-03-16 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4098892A (xx) |
| JP (1) | JPS52118483A (xx) |
| AR (1) | AR210207A1 (xx) |
| AT (1) | AT349478B (xx) |
| BE (1) | BE852813A (xx) |
| CA (1) | CA1070306A (xx) |
| CH (1) | CH624112A5 (xx) |
| DE (1) | DE2711746B2 (xx) |
| DK (1) | DK141065B (xx) |
| ES (1) | ES456945A1 (xx) |
| FR (1) | FR2346349A1 (xx) |
| GB (1) | GB1511218A (xx) |
| NL (1) | NL166941C (xx) |
| PT (1) | PT66360B (xx) |
| SE (1) | SE419083B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5735587A (en) * | 1980-06-04 | 1982-02-26 | Nippon Shinyaku Co Ltd | Benzoguanamine derivative |
| GR74944B (xx) * | 1980-07-02 | 1984-07-12 | Merck & Co Inc | |
| JPS57203083A (en) * | 1981-06-05 | 1982-12-13 | Nippon Shinyaku Co Ltd | Nicotinic acid derivative |
| JPS59106473A (ja) * | 1982-12-10 | 1984-06-20 | Nippon Shinyaku Co Ltd | トリアジン誘導体 |
| GB2204791B (en) * | 1987-05-20 | 1990-09-26 | Nippon Shinyaku Co Ltd | Nootropic agent |
| WO2010046780A2 (en) * | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2822347A (en) * | 1955-06-03 | 1958-02-04 | American Cyanamid Co | Method of preparing triazinyl compositions and products thereof |
-
1976
- 1976-03-29 JP JP3494976A patent/JPS52118483A/ja active Granted
-
1977
- 1977-02-11 GB GB5689/77A patent/GB1511218A/en not_active Expired
- 1977-02-18 US US05/769,948 patent/US4098892A/en not_active Expired - Lifetime
- 1977-03-16 CH CH330477A patent/CH624112A5/de not_active IP Right Cessation
- 1977-03-17 DE DE2711746A patent/DE2711746B2/de active Granted
- 1977-03-17 ES ES456945A patent/ES456945A1/es not_active Expired
- 1977-03-23 BE BE176065A patent/BE852813A/xx not_active IP Right Cessation
- 1977-03-24 FR FR7708825A patent/FR2346349A1/fr active Granted
- 1977-03-24 AT AT205677A patent/AT349478B/de not_active IP Right Cessation
- 1977-03-24 SE SE7703395A patent/SE419083B/xx not_active IP Right Cessation
- 1977-03-25 NL NL7703239.A patent/NL166941C/xx not_active IP Right Cessation
- 1977-03-28 CA CA274,916A patent/CA1070306A/en not_active Expired
- 1977-03-28 PT PT66360A patent/PT66360B/pt unknown
- 1977-03-28 DK DK136277AA patent/DK141065B/da not_active IP Right Cessation
- 1977-03-28 AR AR267002A patent/AR210207A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| AR210207A1 (es) | 1977-06-30 |
| NL166941C (nl) | 1981-10-15 |
| NL7703239A (nl) | 1977-10-03 |
| SE419083B (sv) | 1981-07-13 |
| DK141065B (da) | 1980-01-07 |
| PT66360A (en) | 1977-04-01 |
| SE7703395L (sv) | 1977-09-30 |
| FR2346349B1 (xx) | 1980-07-25 |
| FR2346349A1 (fr) | 1977-10-28 |
| DE2711746C3 (xx) | 1979-06-28 |
| CA1070306A (en) | 1980-01-22 |
| AT349478B (de) | 1979-04-10 |
| GB1511218A (en) | 1978-05-17 |
| DE2711746A1 (de) | 1977-10-06 |
| ES456945A1 (es) | 1978-02-01 |
| ATA205677A (de) | 1978-09-15 |
| NL166941B (nl) | 1981-05-15 |
| DK136277A (xx) | 1977-09-30 |
| DE2711746B2 (de) | 1978-11-23 |
| PT66360B (en) | 1978-08-22 |
| DK141065C (xx) | 1980-06-16 |
| US4098892A (en) | 1978-07-04 |
| JPS5547637B2 (xx) | 1980-12-01 |
| BE852813A (fr) | 1977-07-18 |
| JPS52118483A (en) | 1977-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH615919A5 (xx) | ||
| DE3442035A1 (de) | 6-vinyl-furo-(3,4-c)-pyridin-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzung | |
| DE2407115A1 (de) | Neue 1,4-dihydropyridinderivate | |
| DE2634433A1 (de) | Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE1906527C3 (de) | Thioninderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, welche diese enthalten | |
| CH624112A5 (xx) | ||
| DE3121922C2 (de) | 2-Amino-4-nicotinoylamino-6-halogenphenyl-s-triazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE2804949A1 (de) | Substituierte tetrazolverbindungen | |
| EP0021338B1 (de) | Neue Chinazolinderivate und pharmazeutische Präparate | |
| DE1445950B2 (de) | 2,6-bis-(hydroxymethyl)-pyridindicarbamat-derivate und verfahren zu ihrer herstellung | |
| DE3538063A1 (de) | 6-phenethylaminoalkyl-furo-(3,4-c)-pyridinderivate, verfahren zu deren herstellung und diese enthaltende therapeutische zusammensetzungen | |
| DE2737520A1 (de) | Tetrahydropyridylderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| DE2843136C3 (de) | 6-O-Mono- und 1,6-O-Di-acylierte 2-[3-(2-Chloräthyl)-3-nitroscureido]-2-desoxy-D-glukopyranosen sowie Gemische aus 1,3,6-O-Tri und 1,4,6-O-Tri-acylierten 2-[3-(2-Chloräthyl)-3-nitrosoureido]-2-desoxy-D-glukopyranosen | |
| DE1595894A1 (de) | Neue 1,5-Diazabicyclo[3,3,0]octan-2,6-dione | |
| DE2521347B2 (de) | Hydroxylsubstituierte 2-Chlor- a -(tertbutylaminomethyD-benzylalkohole, Herstellungsverfahren und Arzneimittel | |
| DE2322073A1 (de) | Neue aminoderivate von pyridopyridazincarbonsaeureestern und -carbonsaeuren mit ihren salzen | |
| DE3531004C2 (xx) | ||
| DE2932259A1 (de) | 1-phthalazonderivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE2610679C2 (de) | Sulfinylgruppenhaltige Oximätherderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE3330192A1 (de) | 4-alkylimidazol-derivate, ihre herstellung und verwendung | |
| DE2810774A1 (de) | Ergotderivate, ihre verwendung und herstellung | |
| DE2026040A1 (de) | Imidazolnbosylcyclophosphate | |
| US4506075A (en) | Process of preparing cardiotonic 3-methyl-4-(4-pyridinyl)benzeneamines | |
| AT216152B (de) | Verfahren zur Herstellung von Diestern der Deserpidinsäure und deren Salzen | |
| DE1958329B2 (de) | Verfahren zur Reinigung von Cephaloglycin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |